Search for: "Allergan, Inc. v. Apotex Inc"
Results 1 - 20
of 44
Sort by Relevance
|
Sort by Date
7 Dec 2021, 8:33 am
See Allergan, Inc. v. [read post]
17 Mar 2020, 1:32 pm
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
25 Feb 2020, 2:10 am
See, e.g., Allergan, Inc. v. [read post]
9 Nov 2017, 4:00 am
In that decision (Apotex Inc. v. [read post]
6 May 2017, 10:11 am
Similarly, in Allergan, Inc. v. [read post]
8 Jul 2016, 4:00 am
Apotex Inc., 2016 FC 344 at para 13). [read post]
5 Jul 2016, 12:43 pm
5 Jul 2016, 12:43 pm
5 Jul 2016, 12:43 pm
29 May 2016, 4:00 am
https://t.co/urV3tn3G8G Wednesday, May 25 (Ottawa) -> No settlement agreement by exchange of letters and emails Apotex Inc. v. [read post]
26 May 2016, 4:00 am
No settlement agreement by exchange of letters and emails Apotex Inc. v. [read post]
10 Feb 2016, 12:42 pm
Compare Allergan, Inc. v. [read post]
19 Apr 2015, 9:56 pm
Apotex Inc. et al. 1:15-cv-02676; filed April 15, 2015... [read post]
23 Mar 2015, 5:23 pm
Ct. 831,841 (2015)(claim construction);Allergan, Inc. v. [read post]
21 Mar 2015, 6:26 am
Reference IPR2015-00858.Although this claim survived litigation challenge in Allergan, Inc. v. [read post]
21 Nov 2014, 4:00 am
As would be expected, Apotex (generic2) successfully requested that at least a portion of Allergan’s court materials in case1 be filed publicly, prior to the filing of Apotex’s factum. [read post]
2 Sep 2014, 9:41 pm
Allergan had asserted its 7,351,404 patent (the '404 patent) and Duke asserted its 7,388,029 patent (the '029 patent) after Apotex filed an ANDA for a generic version of Allergan's Latisse®, an ophthalmic solution comprising bimatoprost (a prostaglandin F-2-alpha ("PGF") analog) as the active ingredient. [read post]
12 Jun 2014, 10:41 am
Allergan, Inc. v. [read post]
10 Jun 2014, 5:25 pm
from the case Allergan v. [read post]
22 Apr 2014, 11:29 pm
Aswe held in Allergan, Inc. v. [read post]